Study of Itacitinib in Combination With Docetaxel in Subjects With Non-Small Cell Lung Cancer
Clinical trial NCT02257619 · TERMINATED
Trial details
- NCT number
- NCT02257619
- Sponsor
- Incyte Corporation
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-24
- Primary completion
- 2016-02-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.